Ingredion

Ingredion announced at the Barclays conference a strategic shift toward higher-margin texture and health solutions, highlighting the planned acquisition of Tate & Lyle as central to the transformation. The deal is expected to create a combined texture business with more than $5 billion in sales, deliver $130 million in annual cost synergies, and boost adjusted EPS by 15% or more after closing. The Argo plant in Illinois remains an operational drag—it has stabilized but will take time to fully recover; Ingredion also emphasizes disciplined capital allocation, continued dividends and buybacks, and a focus on India as a growth market. » More on de.investing.com

Ingredion names Diego Reynoso chief financial officer effective October 1, 2026. Reynoso joins from the Boston Beer Company and will report to CEO Jim Zallie on the executive team; his responsibilities include financial leadership, investor relations, IT, M&A, capital allocation and acquisition integration. The company highlights Reynoso’s experience with integrations and portfolio adjustments in the food and beverage industry. » More on de.investing.com

Ingredion posted reported operating income of $188m in Q2 2026 (−31%) and reported diluted EPS of $1.78; adjusted EPS was $2.82. Net sales rose slightly by 1%, supported by volume growth in Texture & Healthful Solutions, while Food & Industrial Ingredients – U.S./Canada and LATAM reported declines in results. The sale of the majority stake in the Pakistan business was completed, Tate & Lyle shareholders accepted Ingredion’s cash offer, and the company confirmed its 2026 full-year outlook taking the Pakistan transaction into account. » More on finanzen.net